Patent | Date |
---|
Angiogenically Effective Unit Dose Of FGF And Method Of Administering App 20180221446 - Whitehouse; Martha J. ;   et al. | 2018-08-09 |
Angiogenically Effective Unit Dose Of Fgf And Method Of Administering App 20160120943 - Whitehouse; Martha J. ;   et al. | 2016-05-05 |
Method of treating coronary artery disease by administering FGF-9 Grant 9,149,507 - Whitehouse , et al. October 6, 2 | 2015-10-06 |
Angiogenically Effective Unit Dose Of Fgf And Method Of Administering App 20140142038 - Whitehouse; Martha J. ;   et al. | 2014-05-22 |
Method of treating coronary artery disease by administering FGF-5 Grant 8,618,052 - Whitehouse , et al. December 31, 2 | 2013-12-31 |
Method of treating coronary artery disease by administering FGF-5 Grant 08618052 - | 2013-12-31 |
Method of treating dyspnea associated with acute heart failure by administering H2 relaxin Grant 8,415,301 - Unemori , et al. April 9, 2 | 2013-04-09 |
Method of treating dyspnea associated with acute heart failure Grant 8,372,809 - Unemori , et al. February 12, 2 | 2013-02-12 |
Angiogenically Effective Unit Dose Of Fgf And Method Of Administering App 20120165245 - Whitehouse; Martha J. ;   et al. | 2012-06-28 |
Method For Treating Dyspnea Associated With Acute Heart Failure App 20120040903 - Unemori; Elaine ;   et al. | 2012-02-16 |
Method Of Treating Chronic Heart Failure App 20110144019 - Unemori; Elaine ;   et al. | 2011-06-16 |
Angiogenically effective unit dose of FGF and method of administering Grant 7,858,584 - Whitehouse , et al. December 28, 2 | 2010-12-28 |
Angiogenically Effective Unit Dose Of Fgf And Method Of Administering App 20090170776 - Whitehouse; Martha J. ;   et al. | 2009-07-02 |
Method of treating coronary artery disease by administering FGF-4 Grant 7,511,019 - Whitehouse , et al. March 31, 2 | 2009-03-31 |
Prevention of Arterial Restenosis with Active Vitamin D Compounds App 20070148205 - Whitehouse; Martha J. ;   et al. | 2007-06-28 |
Prevention of arterial restenosis with active vitamin d compounds App 20070142339 - Whitehouse; Martha J. ;   et al. | 2007-06-21 |
Angiogenically effective unit dose of FGF-2 and method of use App 20070142283 - Whitehouse; Martha J. | 2007-06-21 |
Methods of using vitamin D compounds in the treatment of myelodysplastic syndromes App 20070027120 - Whitehouse; Martha J. ;   et al. | 2007-02-01 |
Pharmaceutical compositions comprising active vitamin D compounds App 20070003614 - Chen; Andrew X. ;   et al. | 2007-01-04 |
Angiogenically effective unit dose of FGF-2 and method of use Grant 7,112,560 - Whitehouse September 26, 2 | 2006-09-26 |
Treatment of immune-mediated disorders with active vitamin D compounds alone or in combination with other therapeutic agents App 20060178351 - Curd; John G. ;   et al. | 2006-08-10 |
Treatment of lung cancer with active vitamin D compounds in combination with other treatments App 20060172014 - Curd; John G. ;   et al. | 2006-08-03 |
Angiogenically effective unit dose fo FGF and method of adminstering App 20060025343 - Whitehouse; Martha J. ;   et al. | 2006-02-02 |
Angiogenically effective unit dose of FGF-2 and method of use App 20050143298 - Whitehouse, Martha J. | 2005-06-30 |
Methods of using vitamin D compounds in the treatment of myelodysplastic syndromes App 20050101576 - Whitehouse, Martha J. ;   et al. | 2005-05-12 |
Pharmaceutical compositions comprising active vitamin D compounds App 20050026877 - Chen, Andrew X. ;   et al. | 2005-02-03 |
Pharmaceutical compositions comprising active vitamin D compounds App 20030191093 - Chen, Andrew X. ;   et al. | 2003-10-09 |
Angiogenically effective unit dose of FGF and method of administering App 20020165160 - Whitehouse, Martha J. | 2002-11-07 |
Angiogenically effective unit dose of FGF-2 and method of use App 20020072489 - Whitehouse, Martha J. | 2002-06-13 |